CLPT (ClearPoint Neuro) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLPT ClearPoint Neuro Inc CLPT
63 GF Score
Price $15.13
GF Value $14.14
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is ClearPoint Neuro 5-Year Yield-on-Cost %?

ClearPoint Neuro CLPT +1.61% 63 5-Year Yield-on-Cost % is 0.00 as of Aug. 12, 2026. GuruFocus rates CLPT with a GF Score™ of 63/100 and a GF Value™ of $14.14 (Fairly Valued). The stock has 8 warning signs investors should review. Among 318 Medical Devices & Instruments companies, ClearPoint Neuro ranks worse than 314465.09% on this metric.

ClearPoint Neuro's yield on cost for the quarter that ended in Jun. 2026 was 0.00.


The historical rank and industry rank for ClearPoint Neuro's 5-Year Yield-on-Cost % or its related term are showing as below:



CLPT's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.355
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

ClearPoint Neuro  (NAS:CLPT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


ClearPoint Neuro 5-Year Yield-on-Cost % Related Terms


CLPT vs SI, PACB, DCTH: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, ClearPoint Neuro's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClearPoint Neuro 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where ClearPoint Neuro's 5-Year Yield-on-Cost % falls into.


CLPT
63GF Score
ClearPoint Neuro Inc CLPT
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ClearPoint Neuro 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of ClearPoint Neuro is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
ClearPoint Neuro (CLPT) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on ClearPoint Neuro and its competitors. According to the industry distribution chart, ClearPoint Neuro ranks #999999 out of 318 companies in the Medical Devices & Instruments industry.
Is ClearPoint Neuro's 5-Year Yield-on-Cost % too high?
ClearPoint Neuro's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, ClearPoint Neuro ranks #999999 out of 318 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, ClearPoint Neuro has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ClearPoint Neuro's 5-Year Yield-on-Cost % compare to SI and PACB?
According to the Medical Devices & Instruments industry distribution chart, ClearPoint Neuro ranks #999999 out of 318 companies for 5-Year Yield-on-Cost %. This places ClearPoint Neuro in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.36, based on 318 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on ClearPoint Neuro and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ClearPoint Neuro's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ClearPoint Neuro stock overvalued right now?
Based on GuruFocus' analysis, ClearPoint Neuro (CLPT) is currently considered Fairly Valued. The stock's GF Value™ is $14.14, compared to a current price of $15.13 — trading 7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. ClearPoint Neuro's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For ClearPoint Neuro (CLPT), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ClearPoint Neuro (CLPT) Overvalued in 2026?

Based on GuruFocus' analysis, ClearPoint Neuro stock appears to be overvalued. The current stock price of $15.13 is trading 7% above its estimated GF Value™ of $14.14. GuruFocus considers ClearPoint Neuro to be Fairly Valued.

Key valuation signals for CLPT:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $14.14 vs. price of $15.13 (7% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the CLPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ClearPoint Neuro Business Description

Address 120 S. Sierra Avenue, Suite 100, Solana Beach, CA, USA, 92075
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
63GF Score

Get the complete analysis for CLPT

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.13
Price
$14.14
GF Value